Victor Manuel Montori, MD, MSc

Accepting PhD Students

  • 52160 Citations
  • 106 Scopus h-Index
19982021
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1998 2019

Filter
Comment/debate
2019

The Rise and Fall of Mesh in Pelvic Surgery and the Shortcomings of Medical Device Regulation

Trabuco, E. C. & Montori, V. M., Jan 1 2019, In : Obstetrical and Gynecological Survey. 74, 1, p. 23-24 2 p.

Research output: Contribution to journalComment/debate

Medical Device Legislation
2018

Commentary

Egan, A. M. & Montori, V. M., Jul 17 2018, In : Annals of Internal Medicine. 169, 2, p. JC2-JC3

Research output: Contribution to journalComment/debate

Commentary

Rodriguez-Gutierrez, R. & Montori, V. M., Mar 20 2018, In : Annals of Internal Medicine. 168, 6, p. JC33

Research output: Contribution to journalComment/debate

Erratum: Aspirin for the primary prevention of cardiovascular events. A systematic review and meta-analysis comparing patients with and without diabetes (Diabetes Care (2009) 32 (2300-2306) DOI: 10.2337/dc09-1297)

Calvin, A. D., Aggarwal, N. R., Murad, M. H., Shi, Q. D., Elamin, M. B., Geske, J. B., Fernandez-Balsells, M. M., Albuquerque, F. N., Lampropulos, J. F., Erwin, P. J., Smith, S. A. & Montori, V. M., Jun 1 2018, In : Diabetes Care. 41, 6, p. 1321-1322 2 p.

Research output: Contribution to journalComment/debate

Primary Prevention
Aspirin
Meta-Analysis
Manuscripts
Diabetic Retinopathy
1 Citation (Scopus)

Review: Newer second-line drugs for diabetes are not more cost-effective than sulfonylureas

Genere, N. & Montori, V. M., Jan 16 2018, In : Annals of Internal Medicine. 168, 2, p. JC8

Research output: Contribution to journalComment/debate

Costs and Cost Analysis
Pharmaceutical Preparations
2017

Guideline: In type 2 diabetes, ACP recommends metformin monotherapy if drugs are needed for glycemic control

Rodriguez-Gutierrez, R. & Montori, V. M., Apr 18 2017, In : Annals of Internal Medicine. 166, 8, p. JC39

Research output: Contribution to journalComment/debate

4 Citations (Scopus)

Measurement with a wink

Kunneman, M., Montori, V. M. & Shah, N. D., Oct 1 2017, In : BMJ Quality and Safety. 26, 10, p. 849-851 3 p.

Research output: Contribution to journalComment/debate

Value of screening for and treating pre-diabetes is reduced by low test accuracy and indirect evidence of impact on patient important outcomes

Alvarez-Villalobos, N. A., Rodriguez-Gutierrez, R. & Montori, V. M., Oct 1 2017, In : Evidence-Based Medicine. 22, 5, p. 180-181 2 p.

Research output: Contribution to journalComment/debate

2016

Existing evidence is insufficient to justify metformin or other agents as first-line therapy for type 2 diabetes

Rodriguez-Gutierrez, R. & Montori, V. M., Dec 1 2016, In : Evidence-Based Medicine. 21, 6, p. 224 1 p.

Research output: Contribution to journalComment/debate

Metformin
Type 2 Diabetes Mellitus
Therapeutics
2 Citations (Scopus)

In insulin-treated type 1 diabetes, canagliflozin increased diabetic ketoacidosis

Sfeir, J. G., Montori, V. M. & Peters, A., Jul 19 2016, In : Annals of Internal Medicine. 165, 2, p. JC2

Research output: Contribution to journalComment/debate

1 Citation (Scopus)

Minimally Disruptive Diabetes Care for the Elderly

Spencer-Bonilla, G., Rodriguez-Gutierrez, R. & Montori, V. M., Dec 1 2016, In : Diabetes Technology and Therapeutics. 18, 12, p. 759-761 3 p.

Research output: Contribution to journalComment/debate

Review: In diabetes, benefits of lowering BP depend on baseline BP being 140 mm Hg or more

Mantilla, L. L. & Montori, V. M., Jun 21 2016, In : Annals of Internal Medicine. 164, 12, p. JC62

Research output: Contribution to journalComment/debate

11 Citations (Scopus)

What we don't talk about when we talk about preventing type 2 diabetes - Addressing socioeconomic disadvantage

Bonilla, G. S., Rodriguez-Gutierrez, R. & Montori, V. M., Aug 1 2016, In : JAMA Internal Medicine. 176, 8, p. 1053-1054 2 p.

Research output: Contribution to journalComment/debate

Type 2 Diabetes Mellitus